Filing Details
- Accession Number:
- 0001104659-17-035312
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-25 19:08:03
- Reporting Period:
- 2017-05-24
- Filing Date:
- 2017-05-25
- Accepted Time:
- 2017-05-25 19:08:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1356576 | Supernus Pharmaceuticals Inc | SUPN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1539215 | P. Padmanabh Bhatt | C/O Supernus Pharmaceuticals, Inc. 1550 East Gude Drive Rockville MD 20850 | Sr. Vp Of Ip, Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-05-24 | 1,613 | $34.90 | 43,887 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-05-25 | 3,887 | $34.90 | 40,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to a Rule 10b5-1 trading plan adopted March 24, 2017.
Billionaire Hedge Funds
